European Archives - Page 384 of 1104 - European Medical Journal

Comparative Performance of Stents in 3D-printed Left Main Bifurcation Models

Percutaneous coronary intervention of bifurcation lesions accounts for approximately 20% of intervention and leads to higher risk…

The Danger of Disappearing Allergen Skin Test Substances

Allergic diseases affect approximately one-quarter to one-half of the average population under 50 years of age in Central Europe…

Flaws in 30-Day Mortality as a Quality Indicator for Coronary Interventions

The accurate appraisal of operator and programmatic quality of percutaneous coronary interventions (PCI) is a fundamental principle of…

The Effect of Side Branch Pre-dilatation on Long-term Mortality in Patients with Coronary Bifurcation Stenting

For more than 20 years, there has been considerable progress in the treatment of coronary bifurcation lesions. The one-stent technique…

GETTING to the ROOT of PsA & axSpA

Discuss treatment options for PsA, according to updated GRAPPA treatment recommendations, available data and patient perspectives

Pharma, Pride and the LGBTQ+ community

This week, the GOLD team looks into how the industry can support patients and staff in the LGBTQ+ community.

Precision Medicine in Systemic Lupus Erythematosus

A session on precision medicine in systemic lupus erythematosus (SLE) took place at the European Alliance of Associations for Rheumatology…

Skin Deep: Insights into Dermatology, Carcinogenesis, and Social Media - Part 2

Christine Ko re-joins Jonathan Sackier to discuss cognitive bias, carcinogenesis, and visual perception in dermatology and dermatopathology.

Are Kidney Cancer Mortality Rates Decreasing Across the USA?

Over the past two decades, age-adjusted mortality rates in kidney cancer have decreased across all genders, races, and ethnicities.

New Tool Helps Promote Cardiovascular Health Discussions with Survivors of Cancer

Cardiovascular disease may pose a greater risk to many post-treatment survivors of cancer than cancer recurrence.